glaucoma patients Lipiflow meibomian gland dysfunction topical glaucoma medication
Conditions
Interventions
Single treatment with Lipiflow instrument,
lid hygiene,patient performs well-
instructed standard lid hygiene at least once a day
Lipiflow,Lid hygiene
Sponsors
None
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Age more than 18 years old 2.Prescribed with one or more topical anti-glaucoma medications in both eyes 3.Diagnosed with MGD stage II or stage III
Exclusion criteria
Exclusion criteria: 1.Blindness or have one eye 2.Underwent trabeculectomy procedure 3.Have advance glaucoma or uncontrolled IOP 4.Have history of ocular surgery or injury within prior 3 months 5.Have history of ocular herpes within prior 3 months 6.Have active ocular inflammation or infection 7.Have eyelid or ocular surface abnormalities 8.Diagnoses with systemic disease causing dry eye
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| meibomian gland expressibility 1 week, 1 month, 3 month, 6 month after intervention meibomian gland express score | — |
Secondary
| Measure | Time frame |
|---|---|
| Dry eye symptoms 1 week, 1 month, 3 month, 6 month after intervention interview with questionnaire OSDI score,Tear film stability 1 week, 1 month, 3 month, 6 month after intervention slit lamp examination with tear break up time test,Corneal surface 1 week, 1 month, 3 month, 6 month after intervention Slit lamp examination with corneal staining Oxford score,Tear film lipid layer thickness 1 week, 1 month, 3 month, 6 month after intervention measure with Lipiview instrument,Tear production 1 week, 1 month, 3 month, 6 month after intervention Schirmer's test,meibomian gland drop out 1 week, 1 month, 3 month, 6 month after intervention using meibography | — |
Countries
Thailand
Contacts
Public ContactNgamjit Kasetsuwan
Chulalongkorn University
Outcome results
None listed